Shockwave Coronary Lithoplasty® Study (Disrupt CAD II)

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 18, 2018

Primary Completion Date

March 26, 2019

Study Completion Date

April 25, 2019

Conditions
Coronary Artery Disease
Interventions
DEVICE

IVL Coronary Lithotripsy System

The coronary intravascular lithotripsy catheter is similar to other balloon devices that are routinely used during angioplasty procedures; however, it has electrodes inside the balloon which are designed to deliver energy to crack the calcified blockage using lithotripsy (acoustic energy).

Trial Locations (15)

Unknown

Onze-Lieve-Vrouwziekenhuis, Aalst

Aarhus Universitetshospital, Aarhus

Institut Hospitalier Jacques Cartier, Massy

Clinique Pasteur, Toulouse

Universitaets-Herzzentrum Freiburg- Bad Krozingen, Bad Krozingen

Universitaetsklinikum Bonn, Bonn

UKGM Universitaetsklinikum Giessen, Giessen

AOU Careggi SOD Interventistica, Florence

San Raffaelle Hospital, Milan

Thorax Center, Erasmus MC, Rotterdam

Isala Zeikenhuis- Hartecentrum, Zwolle

Hospital Universitario San Carlos, Madrid

Uppsala University Hospital, Uppsala

King's College Hospital, London

Oxford University Hospitals, John Radcliffe Hospital, Oxford

All Listed Sponsors
lead

Shockwave Medical, Inc.

INDUSTRY

NCT03328949 - Shockwave Coronary Lithoplasty® Study (Disrupt CAD II) | Biotech Hunter | Biotech Hunter